Cargando…

Epigenetics and Liver Fibrosis

Liver fibrosis arises because prolonged injury combined with excessive scar deposition within hepatic parenchyma arising from overactive wound healing response mediated by activated myofibroblasts. Fibrosis is the common end point for any type of chronic liver injury including alcoholic liver diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Moran-Salvador, Eva, Mann, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453904/
https://www.ncbi.nlm.nih.gov/pubmed/28593184
http://dx.doi.org/10.1016/j.jcmgh.2017.04.007
_version_ 1783240733315039232
author Moran-Salvador, Eva
Mann, Jelena
author_facet Moran-Salvador, Eva
Mann, Jelena
author_sort Moran-Salvador, Eva
collection PubMed
description Liver fibrosis arises because prolonged injury combined with excessive scar deposition within hepatic parenchyma arising from overactive wound healing response mediated by activated myofibroblasts. Fibrosis is the common end point for any type of chronic liver injury including alcoholic liver disease, nonalcoholic fatty liver disease, viral hepatitis, and cholestatic liver diseases. Although genetic influences are important, it is epigenetic mechanisms that have been shown to orchestrate many aspects of fibrogenesis in the liver. New discoveries in the field are leading toward the development of epigenetic biomarkers and targeted therapies. This review considers epigenetic mechanisms as well as recent advances in epigenetic programming in the context of hepatic fibrosis.
format Online
Article
Text
id pubmed-5453904
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54539042017-06-07 Epigenetics and Liver Fibrosis Moran-Salvador, Eva Mann, Jelena Cell Mol Gastroenterol Hepatol Review Liver fibrosis arises because prolonged injury combined with excessive scar deposition within hepatic parenchyma arising from overactive wound healing response mediated by activated myofibroblasts. Fibrosis is the common end point for any type of chronic liver injury including alcoholic liver disease, nonalcoholic fatty liver disease, viral hepatitis, and cholestatic liver diseases. Although genetic influences are important, it is epigenetic mechanisms that have been shown to orchestrate many aspects of fibrogenesis in the liver. New discoveries in the field are leading toward the development of epigenetic biomarkers and targeted therapies. This review considers epigenetic mechanisms as well as recent advances in epigenetic programming in the context of hepatic fibrosis. Elsevier 2017-04-26 /pmc/articles/PMC5453904/ /pubmed/28593184 http://dx.doi.org/10.1016/j.jcmgh.2017.04.007 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Moran-Salvador, Eva
Mann, Jelena
Epigenetics and Liver Fibrosis
title Epigenetics and Liver Fibrosis
title_full Epigenetics and Liver Fibrosis
title_fullStr Epigenetics and Liver Fibrosis
title_full_unstemmed Epigenetics and Liver Fibrosis
title_short Epigenetics and Liver Fibrosis
title_sort epigenetics and liver fibrosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453904/
https://www.ncbi.nlm.nih.gov/pubmed/28593184
http://dx.doi.org/10.1016/j.jcmgh.2017.04.007
work_keys_str_mv AT moransalvadoreva epigeneticsandliverfibrosis
AT mannjelena epigeneticsandliverfibrosis